Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Fujitaki

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Chromatography|December 19, 1980
High-performance liquid chromatography of acid-stable and acid-labile phosphoamino acidsA W Steiner, E R Helander, J M Fujitaki, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Potent and specific inhibitors of mammalian phosphoribosylpyrophosphate (PRPP) synthetaseR C Willis, L D Nord, J M Fujitaki, et al.
Biochemistry|May 6, 1986
Covalent linkage of phospholipid to myelin basic protein: identification of serine-54 as the site of attachmentP C Chang, J C Yang, J M Fujitaki, et al.
Preparative Biochemistry|January 1, 1980
A simple preparation of N-phosphorylated lysine and arginineJ M Fujitaki, A W Steiner, S E Nichols, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Design, synthesis, and structure-activity relationships of the first highly potent, selective, and bioavailable adenosine 5'-monophosphate deaminase inhibitorsS R Kasibhatla, B C Bookser, J R Appleman, et al.
Journal of Medicinal Chemistry|February 1, 1988
Synthesis and evaluation of 5-amino-1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine and certain related nucleosides as inhibitors of purine nucleoside phosphorylaseY S Sanghvi, N B Hanna, S B Larson, et al.
Advances in Enzyme Regulation|January 1, 1989
Nucleoside and nucleotide modulation of genetic expression--a new approach to chemotherapyR K Robins, E Ojo-Amaize, Z Parandoosh, et al.
Biochemical Pharmacology|February 1, 1990
Inhibition of pyrimidine metabolism in myeloid leukemia cells by triazole and pyrazole nucleosidesS S Matsumoto, J M Fujitaki, L D Nord, et al.
British Journal of Pharmacology|February 3, 2009
Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeysB R Ito, B-H Zhang, E E Cable, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Chromatography|December 19, 1980
High-performance liquid chromatography of acid-stable and acid-labile phosphoamino acidsA W Steiner, E R Helander, J M Fujitaki, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Potent and specific inhibitors of mammalian phosphoribosylpyrophosphate (PRPP) synthetaseR C Willis, L D Nord, J M Fujitaki, et al.
Biochemistry|May 6, 1986
Covalent linkage of phospholipid to myelin basic protein: identification of serine-54 as the site of attachmentP C Chang, J C Yang, J M Fujitaki, et al.
Preparative Biochemistry|January 1, 1980
A simple preparation of N-phosphorylated lysine and arginineJ M Fujitaki, A W Steiner, S E Nichols, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Design, synthesis, and structure-activity relationships of the first highly potent, selective, and bioavailable adenosine 5'-monophosphate deaminase inhibitorsS R Kasibhatla, B C Bookser, J R Appleman, et al.
Journal of Medicinal Chemistry|February 1, 1988
Synthesis and evaluation of 5-amino-1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine and certain related nucleosides as inhibitors of purine nucleoside phosphorylaseY S Sanghvi, N B Hanna, S B Larson, et al.
Advances in Enzyme Regulation|January 1, 1989
Nucleoside and nucleotide modulation of genetic expression--a new approach to chemotherapyR K Robins, E Ojo-Amaize, Z Parandoosh, et al.
Biochemical Pharmacology|February 1, 1990
Inhibition of pyrimidine metabolism in myeloid leukemia cells by triazole and pyrazole nucleosidesS S Matsumoto, J M Fujitaki, L D Nord, et al.
British Journal of Pharmacology|February 3, 2009
Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeysB R Ito, B-H Zhang, E E Cable, et al.
Pageof 2